DDX5 and glioblastoma: The results of CPTAC revealed that the total expression of DDX5 protein was considerably higher in eight cancer types, including ovarian cancer, breast cancer, GBM, HNSC, UCEC, LUAD, colon cancer, and hepatocellular carcinoma, compared to that of matched normal tissues (Figure 2B, p < 0.001).